# A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

> **NCT06000891** · PHASE1 · TERMINATED · sponsor: **Zealand Pharma** · enrollment: 84 (actual)

## Conditions studied

- Safety and Tolerability

## Interventions

- **DRUG:** ZP7570
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06000891
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-09-15
- **Primary completion:** 2025-02-11
- **Final completion:** 2025-03-21
- **Target enrollment:** 84 (ACTUAL)
- **Why stopped:** Decision by Sponsor; LSLV was completed on 21-Mar-2025 as planned.
- **Last updated:** 2025-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06000891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06000891, "A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06000891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*